Retender radar: UK public contracts ending soon
Every contract on Find a Tender with a published end date in the future, one row per contract (lot). A contract ending is a procurement starting — unless the buyer uses a published extension option, which the row shows. Frameworks and DPS are marked: what ends there is the vehicle, not one supplier’s contract.
When contracts end · Medical equipments, pharmaceuticals i
When contracts here run out.
Published contracts by their end date. No end date, not counted.
A likely retender, not a certain one.
i
When contracts here run out.
Published contracts by their end date. No end date, not counted.
A likely retender, not a certain one.
902 contracts end within 24 months, 1,006 in total · £90m published GBP value, exc. VAT, in the next 12 months (framework ceilings included, not a spend forecast).
By sector, next 12 months i
When contracts here run out.
Published contracts by their end date. No end date, not counted.
A likely retender, not a certain one.
i
When contracts here run out.
Published contracts by their end date. No end date, not counted.
A likely retender, not a certain one.
CPV division of the procedure; a contract with several divisions counts in each.
85Health and social work services1,17133Medical equipments, pharmaceuticals59179Business services: law, marketing, consulting48172IT services: consulting, software, internet18580Education and training services17860Transport services (except waste transport)17550Repair and maintenance services16715Food, drink, tobacco164
Contracts ending in the next 12 months
Showing 301–400
- Ends · in 111 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: Brown and Burk UK Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 111 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: Alissa Healthcare Research Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 111 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: Sandoz
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 111 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: Scope Ophthalmics Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 111 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: Milpharm Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 111 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: MSN Laboratories Europe Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 111 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: Biocon
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 111 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: ACCORD-UK LTD
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 111 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: Medreich PLC
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 120 daysFramework re-letPanel · 10 suppliers
Veterinary imaging Systems
APUC Ltd · Nationwide (UK)
Panel: Aquilant Endoscopy Ltd, Canon Medical Systems, IMV imaging UK Ltd +7 more
- Contract value
- £20mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- Ends 9 Feb 2027 · start not published
- Reference
ocds-h6vhtk-044583
- Ends · in 120 daysFramework re-letPanel · 10 suppliers
Veterinary imaging Systems
APUC Ltd · Nationwide (UK)
Panel: Aquilant Endoscopy Ltd, Canon Medical Systems, IMV imaging UK Ltd +7 more
- Contract value
- £20mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- 10 Feb 2024 → 9 Feb 2027 · 2.9 yrs
- Reference
ocds-h6vhtk-044583
- Ends · in 139 daysFramework re-letPanel · 31 suppliers
NP49425 Generic and Biosimilar Transition Medicines
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland
Panel: AOP Orphan Ltd, Accord Healthcare Ltd, Amarox Limited +28 more
- Contract value
- £64mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- Ends 28 Feb 2027 · start not published
- Reference
ocds-h6vhtk-0581ea
- Ends · in 139 daysFramework re-letPanel · 5 suppliers
Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept)
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland
Panel: Celltrion Healthcare United Kingdom Limited, Fresenius Kabi Limited, Janssen-Cilag Ltd +2 more
- Contract value
- £27mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- Ends 28 Feb 2027 · start not published
- Reference
ocds-h6vhtk-0581ea
- Ends · in 139 daysFramework re-letPanel · 2 suppliers
Cytokine Modulators (Omalizumab)
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland
Panel: Celltrion Healthcare United Kingdom Limited, Mercury Pharmaceuticals Limited
- Contract value
- £9.3mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- Ends 28 Feb 2027 · start not published
- Reference
ocds-h6vhtk-0581ea
- Ends · in 149 daysFramework re-let
Supply of Antisera Reagents
NHS Blood and Transplant · NHS & health · Nationwide (UK)
Incumbent: Bio-Rad Laboratories Limited
- Contract value
- £1.9mceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 10 Mar 2027 · start not published
- Reference
ocds-h6vhtk-038a2d
- Ends · in 149 daysFramework re-let
Supply of Antisera Reagents
NHS Blood and Transplant · NHS & health · Nationwide (UK)
Incumbent: IBG Immucor Ltd
- Contract value
- £1.9mceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 10 Mar 2027 · start not published
- Reference
ocds-h6vhtk-038a2d
- Ends · in 149 daysFramework re-let
Supply of Antisera Reagents
NHS Blood and Transplant · NHS & health · Nationwide (UK)
Incumbent: Alpha Laboratories Limited
- Contract value
- £1.9mceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 10 Mar 2027 · start not published
- Reference
ocds-h6vhtk-038a2d
- Ends · in 149 daysFramework re-let
Supply of Antisera Reagents
NHS Blood and Transplant · NHS & health · Nationwide (UK)
Incumbent: Alba Bioscience Limited
- Contract value
- £1.9mceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 10 Mar 2027 · start not published
- Reference
ocds-h6vhtk-038a2d
- Ends · in 149 daysFramework re-let
Supply of Antisera Reagents
NHS Blood and Transplant · NHS & health · Nationwide (UK)
Incumbent: Lorne Laboratories Limited
- Contract value
- £1.9mceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 10 Mar 2027 · start not published
- Reference
ocds-h6vhtk-038a2d
- Ends · in 150 daysExtension option · up to 11 Mar 2029
Supply of Naloxone Nasal Spray
Home Office · Central government · Nationwide (UK)
Incumbent: Orion Medical Supplies Ltd
- Contract value
- £169k
- Annual run-rate
- £169kvalue ÷ published term
- Term
- 12 Mar 2026 → 11 Mar 2027 · 11 months · up to 11 Mar 2029 with extensions
- Reference
ocds-h6vhtk-060344
- Ends · in 170 daysFramework re-letPanel · 5 suppliers
239_24 Provision of Washroom Services
Leeds Beckett University · Education · Nationwide (UK), Yorkshire and the Humber, Greater London
Panel: Elis Cleanroom, Hygiene Solutions & Systems LTD, Personnel Hygiene Services Ltd T/A PHS Group Plc +2 more
- Contract value
- £120mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- Ends 31 Mar 2027 · start not published
- Reference
ocds-h6vhtk-042b9b
- Ends · in 170 days
Tender for the provision of the Technology Enabled Care Service (TECS) in Herefordshire
Herefordshire Council · Local authority · West Midlands
Incumbent: Nottingham Rehab Limited
- Contract value
- £2.5m
- Annual run-rate
- —start date not published
- Term
- Ends 31 Mar 2027 · start not published
- Reference
ocds-h6vhtk-04be9e
- Ends · in 170 days
Rabies vaccine
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · NHS & health · Nationwide (UK)
Incumbent: Valneva UK Ltd
- Contract value
- £1.9m
- Annual run-rate
- —start date not published
- Term
- Ends 31 Mar 2027 · start not published
- Reference
ocds-h6vhtk-034816
- Ends · in 170 daysFramework re-let
The Provision of Nicotine Replacement Therapy for North Northamptonshire Council
North Northamptonshire Council · Local authority · East Midlands
Incumbent: Sigma Pharmaceuticals plc
- Contract value
- £400kceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Mar 2027 · start not published
- Reference
ocds-h6vhtk-0392cf
- Ends · in 170 daysFramework re-letExtension option · up to 31 Mar 2029Buyer plans to re-tender 27 Jan 2029
West Northamptonshire Council - Point of Care Testing (POCT) Equipment and Support Framework for NHS Health Check Services
West Northamptonshire Council · Local authority · East Midlands
Incumbent: BHR Pharmaceuticals Ltd
- Contract value
- £350kceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- 8 May 2026 → 31 Mar 2027 · 10 months · up to 31 Mar 2029 with extensions
- Reference
ocds-h6vhtk-060feb
- Ends · in 170 daysExtension option · up to 31 Mar 2032
Provision of Minor Maintenance and Cleansing of Public Conveniences Lot 2
Swale Borough Council · Local authority · South East England
Incumbent: Monitor Cleaning Services Ltd
- Contract value
- £337k
- Annual run-rate
- £368kvalue ÷ published term
- Term
- 1 May 2026 → 31 Mar 2027 · 11 months · up to 31 Mar 2032 with extensions
- Reference
ocds-h6vhtk-065b95
- Ends · in 170 days
NGH - Nurse Call Upgrade
Northampton General Hospital NHS Trust · Central government · East Midlands
Incumbent: H.R.MANN LIMITED
- Contract value
- £309k
- Annual run-rate
- —not computed
- Term
- 1 Oct 2026 → 31 Mar 2027 · 6 months
- Reference
ocds-h6vhtk-06d30d
- Ends · in 170 days
CWC23163 Supply of Combi Nicotine Replacement Therapy (NRT)
Wolverhampton City Council · Local authority · West Midlands
Incumbent: Central Health Solutions Ltd
- Contract value
- £308k
- Annual run-rate
- —start date not published
- Term
- Ends 31 Mar 2027 · start not published
- Reference
ocds-h6vhtk-0437d9
- Ends · in 170 daysFramework re-let
YPO 1260 ESPO 239_24 Washroom Services - Further competition
Leeds Beckett University · Education · Nationwide (UK), Yorkshire and the Humber, Greater London
Incumbent: Rentokil Initial UK Ltd
- Contract value
- £240kceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Mar 2027 · start not published
- Reference
ocds-h6vhtk-042b9b
- Ends · in 170 days
CBC-1631-T-RM Toxicology/Coroner Services
Central Bedfordshire Council · Local authority · East of England
Incumbent: Central Bedfordshire Council
- Contract value
- £229k
- Annual run-rate
- —start date not published
- Term
- Ends 31 Mar 2027 · start not published
- Reference
ocds-h6vhtk-042afb
- Ends · in 170 daysExtension option · up to 31 Mar 2029
IPMO 2168.12 - High-Speed X-Ray
Defence Science and Technology Laboratory · Central government · Nationwide (UK)
Incumbent: Dynamic Research Innovations Incorporated
- Contract value
- £222k
- Annual run-rate
- £168kvalue ÷ published term
- Term
- 5 Dec 2025 → 31 Mar 2027 · 1.3 yrs · up to 31 Mar 2029 with extensions
- Reference
ocds-h6vhtk-058c24
- Ends · in 170 daysFramework re-let
NC766 Washroom Services
Leeds Beckett University · Education · Nationwide (UK), Yorkshire and the Humber, Greater London
Incumbent: Personnel Hygiene Services Ltd T/A PHS Group Plc
- Contract value
- £160kceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Mar 2027 · start not published
- Reference
ocds-h6vhtk-042b9b
- Ends · in 170 days
Single-molecule counting and digital quantification of RNA molecules instrument
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · Central government · Nationwide (UK)
Incumbent: Bruker Spatial Biology, Inc.
- Contract value
- £111k
- Annual run-rate
- £148kvalue ÷ published term
- Term
- 1 Jul 2026 → 31 Mar 2027 · 9 months
- Reference
ocds-h6vhtk-059f67
- Ends · in 170 daysFramework re-let
NC766 Washroom Services
Leeds Beckett University · Education · Nationwide (UK), Yorkshire and the Humber, Greater London
Incumbent: Rentokil Initial t/a Initial Washroom Hygiene
- Contract value
- £99kceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Mar 2027 · start not published
- Reference
ocds-h6vhtk-042b9b
- Ends · in 170 days
Supply of BD Glucan Test kits
University Hospitals of Derby and Burton NHS Foundation Trust · Central government · Nationwide (UK)
Incumbent: IMMY MDx Ltd
- Contract value
- £82k
- Annual run-rate
- £82kvalue ÷ published term
- Term
- 1 Apr 2026 → 31 Mar 2027 · 11 months
- Reference
ocds-h6vhtk-065fab
- Ends · in 170 days
Orthotic Consumables
The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust · Central government
Incumbent: Allard Support UK Ltd
- Contract value
- £81k
- Annual run-rate
- £81kvalue ÷ published term
- Term
- 1 Apr 2026 → 31 Mar 2027 · 11 months
- Reference
ocds-h6vhtk-066466
- Ends · in 170 days
Ophthalmic Consumables
The Shrewsbury and Telford Hospital NHS Trust · Central government
Incumbent: M.I.S.S. Ophthalmics Limited
- Contract value
- £33k
- Annual run-rate
- £33kvalue ÷ published term
- Term
- 1 Apr 2026 → 31 Mar 2027 · 11 months
- Reference
ocds-h6vhtk-0660ac
- Ends · in 170 days
BCG
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · NHS & health · Nationwide (UK)
Incumbent: AJ Vaccines A/S
- Contract value
- £1
- Annual run-rate
- —start date not published
- Term
- Ends 31 Mar 2027 · start not published
- Reference
ocds-h6vhtk-034f1d
- Ends · in 200 days
European Viper Antivenom (2024)
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · NHS & health · Nationwide (UK)
Incumbent: Flynn Pharma Ltd
- Contract value
- £1
- Annual run-rate
- value ÷ published term
- Term
- 1 May 2024 → 30 Apr 2027 · 2.9 yrs
- Reference
ocds-h6vhtk-03b697
- Ends · in 200 days
European Viper Antivenom (2024)
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · NHS & health · Nationwide (UK)
Incumbent: Flynn Pharma Ltd
- Contract value
- £1
- Annual run-rate
- value ÷ published term
- Term
- 1 May 2024 → 30 Apr 2027 · 2.9 yrs
- Reference
ocds-h6vhtk-03b697
- Ends · in 200 daysFramework re-let
Standard Half-life Recombinant Factor VIII
NHS England · NHS & health · Nationwide (UK)
Incumbent: Pfizer Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
rFIX - Standard Half Life
NHS England · NHS & health · Nationwide (UK)
Incumbent: Pfizer Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
rFIX - Standard Half Life
NHS England · NHS & health · Nationwide (UK)
Incumbent: Takeda UK Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Recombinant Factor VII
NHS England · NHS & health · Nationwide (UK)
Incumbent: Novo Nordisk
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Recombinant Factor VII
NHS England · NHS & health · Nationwide (UK)
Incumbent: LFB
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Porcine Factor VIII - susoctocog alfa
NHS England · NHS & health · Nationwide (UK)
Incumbent: Takeda UK Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Factor VIII Inhibitor Bypassing Fraction
NHS England · NHS & health · Nationwide (UK)
Incumbent: Takeda UK Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Factor IX - High Purity Factor IX
NHS England · NHS & health · Nationwide (UK)
Incumbent: BIO PRODUCTS LABORATORY LIMITED
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Factor X
NHS England · NHS & health · Nationwide (UK)
Incumbent: BIO PRODUCTS LABORATORY LIMITED
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Factor XIII - Plasma Derived
NHS England · NHS & health · Nationwide (UK)
Incumbent: CSL BEHRING UK LIMITED
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Factor XIII - Recombinant
NHS England · NHS & health · Nationwide (UK)
Incumbent: Novo Nordisk
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Standard Half-life Recombinant Factor VIII
NHS England · NHS & health · Nationwide (UK)
Incumbent: Takeda UK Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Von willebrands factor / Factor VIII
NHS England · NHS & health · Nationwide (UK)
Incumbent: Octapharma Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Von willebrands factor / Factor VIII
NHS England · NHS & health · Nationwide (UK)
Incumbent: CSL BEHRING UK LIMITED
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Von willebrands factor - Plasma Derived
NHS England · NHS & health · Nationwide (UK)
Incumbent: LFB
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Von willebrands factor - Recombinant
NHS England · NHS & health · Nationwide (UK)
Incumbent: Takeda UK Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Fibrinogen Concentrate
NHS England · NHS & health · Nationwide (UK)
Incumbent: LFB
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Fibrinogen Concentrate
NHS England · NHS & health · Nationwide (UK)
Incumbent: Octapharma Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Fibrinogen Concentrate
NHS England · NHS & health · Nationwide (UK)
Incumbent: CSL BEHRING UK LIMITED
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Prothrombin Complex dried
NHS England · NHS & health · Nationwide (UK)
Incumbent: Takeda UK Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Prothrombin Complex dried
NHS England · NHS & health · Nationwide (UK)
Incumbent: Octapharma Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Prothrombin Complex dried
NHS England · NHS & health · Nationwide (UK)
Incumbent: CSL BEHRING UK LIMITED
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Standard Half-life Recombinant Factor VIII
NHS England · NHS & health · Nationwide (UK)
Incumbent: Octapharma Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Protein C Concentrate
NHS England · NHS & health · Nationwide (UK)
Incumbent: Takeda UK Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Fresh Frozen Plasma (all blood groups)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Octapharma Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Enhanced Half-life Recombinant Factor VIII
NHS England · NHS & health · Nationwide (UK)
Incumbent: Novo Nordisk
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Enhanced Half-life Recombinant Factor VIII
NHS England · NHS & health · Nationwide (UK)
Incumbent: Sobi (Swedish Orphan Biovitrum Ltd)
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Emicizumab
NHS England · NHS & health · Nationwide (UK)
Incumbent: Roche Products Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
Eftrenonacog alfa (rFIX EHL)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Sobi (Swedish Orphan Biovitrum Ltd)
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
albutrepenonacog alfa (rFIX EHL)
NHS England · NHS & health · Nationwide (UK)
Incumbent: CSL BEHRING UK LIMITED
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 daysFramework re-let
nonacog beta pegol (rFIX EHL)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Novo Nordisk
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-043b0e
- Ends · in 200 days
Varicella-zoster immunoglobulin (VZIG) 2025
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · NHS & health · Nationwide (UK)
Incumbent: BIO PRODUCTS LABORATORY LIMITED
- Contract value
- £1
- Annual run-rate
- —start date not published
- Term
- Ends 30 Apr 2027 · start not published
- Reference
ocds-h6vhtk-047b9e
- Ends · in 200 days
Varicella-zoster immunoglobulin (VZIG) 2025
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · NHS & health · Nationwide (UK)
Incumbent: BIO PRODUCTS LABORATORY LIMITED
- Contract value
- £1
- Annual run-rate
- £1value ÷ published term
- Term
- 1 May 2025 → 30 Apr 2027 · 1.9 yrs
- Reference
ocds-h6vhtk-047b9e
- Ends · in 200 days
Varicella-zoster immunoglobulin (VZIG) 2025
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · NHS & health · Nationwide (UK)
Incumbent: Grifols UK
- Contract value
- £1
- Annual run-rate
- £1value ÷ published term
- Term
- 1 May 2025 → 30 Apr 2027 · 1.9 yrs
- Reference
ocds-h6vhtk-047b9e
- Ends · in 231 daysFramework re-letExtension option · up to 31 May 2029Panel · 5 suppliers
Lot 2 - CM/PHS/25/5728/02
NHS England · Central government · Nationwide (UK), North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands
Panel: Bayer Plc, Biosimilar Collaborations Ireland Limited, Celltrion Healthcare Uk Ltd +2 more
- Contract value
- £783mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- 1 Dec 2025 → 31 May 2027 · 1.4 yrs · up to 31 May 2029 with extensions
- Reference
ocds-h6vhtk-055064
- Ends · in 231 daysFramework re-letExtension option · up to 31 May 2029Panel · 14 suppliers
Lot 1 - CM/PHS/25/5728/01
NHS England · Central government · Nationwide (UK), North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands
Panel: Abbvie Ltd, Alimera Sciences, Bayer Plc +11 more
- Contract value
- £689mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- 1 Dec 2025 → 31 May 2027 · 1.4 yrs · up to 31 May 2029 with extensions
- Reference
ocds-h6vhtk-055064
- Ends · in 231 daysFramework re-letExtension option · up to 31 Jan 2030Panel · 21 suppliers
NHS National Framework for Generics Housekeeping Lot 1 - Oral Products
NHS England · Central government · North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands, East of England
Panel: ACCORD-UK LTD, Alissa Healthcare Research Limited, Brown and Burk UK Ltd +18 more
- Contract value
- £18mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- 1 Feb 2026 → 31 May 2027 · 1.3 yrs · up to 31 Jan 2030 with extensions
- Reference
ocds-h6vhtk-058823
- Ends · in 231 daysFramework re-letExtension option · up to 31 May 2028Panel · 16 suppliers
Lot 1 - CM/PHG/23/5699/01 Oral (plus non-parenteral) products
NHS England · Central government · North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands, East of England
Panel: Amarox Limited, Brown and Burk UK Ltd, Celix Pharma Ltd. +13 more
- Contract value
- £18mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- 1 Jun 2026 → 31 May 2027 · 11 months · up to 31 May 2028 with extensions
- Reference
ocds-h6vhtk-05193a
- Ends · in 231 daysFramework re-letPanel · 29 suppliers
Lot 1.2 - Technology Enabled Care (Telecare) services
ESPO · Nationwide (UK)
Panel: Alcove Limited, Appello Smart Living Solutions, BDS (Northern) Ltd t/a BDS Recruitment +26 more
- Contract value
- £8.8mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-04c625
- Ends · in 231 daysFramework re-letPanel · 22 suppliers
Lot 1.1 - Technology Enabled Care (Telecare) products and associated services
ESPO · Nationwide (UK)
Panel: Access UK Ltd, Alcove Limited, Alertacall Limited +19 more
- Contract value
- £5.6mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-04c625
- Ends · in 231 daysFramework re-letPanel · 13 suppliers
Lot 2.1 - Telehealth products and associated services
ESPO · Nationwide (UK)
Panel: Abilia Ltd, Baywater Healthcare UK Limited, Broomwell Healthwatch Limited +10 more
- Contract value
- £800kceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-04c625
- Ends · in 231 daysFramework re-letPanel · 16 suppliers
Lot 2.2 - Telehealth services
ESPO · Nationwide (UK)
Panel: Baywater Healthcare UK Limited, Broomwell Healthwatch Limited, EVONDOS OY +13 more
- Contract value
- £800kceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-04c625
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Milpharm Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Roma Pharmaceuticals Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Perennial Pharma Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Consilient Health Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Pfizer Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Rosemont Pharmaceuticals Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: GLAXOSMITHKLINE UK LIMITED
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Aventis Pharma Ltd Trading As Sanofi
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Sandoz
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Flynn Pharma Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Dr Reddy's Laboratories (UK) Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Kent Pharma Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Glenmark Pharmaceuticals Europe Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Esteve Pharmaceuticals Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Healthcare Pharma Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Ranbaxy (UK) Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: CST Pharma Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
- Ends · in 231 daysFramework re-let
Wave 14c - Orals (plus non-parenteral) Products (all regions)
NHS England · NHS & health · Nationwide (UK)
Incumbent: Teva UK Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 May 2027 · start not published
- Reference
ocds-h6vhtk-040d4d
How to read the radar
- End date is the contract period end the buyer published on Find a Tender. Contracts without an end date are not on the radar.
- Extension option means the notice publishes a renewal or option clause; the buyer may extend instead of retendering. Hide them to see contracts that must be re-procured.
- Incumbent is the canonical supplier on the award behind the contract. A panel (several suppliers on one award) is shown as a panel — no single incumbent is invented.
- Annual run-rate = published GBP value ÷ published term, only for a single supplier, a term of six months or more and a plain contract (not a framework or DPS ceiling).
- Counts are exact from the nightly projection when you filter by horizon and sector only; any other filter shows a bounded total — exact up to 1,000 contracts, an honest “1,000+” floor above that.